According to filings with the U.S. Securities and Exchange Commission, Hyalex Orthopaedics is raising up to $18,124,761.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Carl Vause played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Hyalex Orthopaedics
Hyalex Orthopaedics is a venture backed Boston-based medical device start-up focused on developing and commercializing new products that feature HYALEX materials technology. Unlike other polymers, synthetic HYALEX material has the unique capability of maintaining low friction and low wear under the high loads encountered in human joints. Hyalex Orthopaedics knee implant is an investigational device limited by Federal (or United States) law to investigational use.

To learn more about Hyalex Orthopaedics, visit http://www.hyalex.com/
Hyalex Orthopaedics Linkedin Page: https://www.linkedin.com/company/hyalex-orthopaedics-inc/

Contact:
Carl Vause, President and Chief Executive Officer
781-778-3232
https://www.linkedin.com/in/carlvause/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.